99 related articles for article (PubMed ID: 25917932)
1. Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59.
Leaderer D; Cashman SM; Kumar-Singh R
J Gene Med; 2015; 17(6-7):101-15. PubMed ID: 25917932
[TBL] [Abstract][Full Text] [Related]
2. Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)?
Madjd Z; Durrant LG; Pinder SE; Ellis IO; Ronan J; Lewis S; Rushmere NK; Spendlove I
Cancer Immunol Immunother; 2005 Feb; 54(2):149-56. PubMed ID: 15378282
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of alpha(1,3)galactosyltransferase and Bacillus thuringiensis PIPLC enhances hyperacute rejection of tumor cells.
Hellrung DJ; Kisselev S; Link CJ
Cancer Immunol Immunother; 2007 Jan; 56(1):25-34. PubMed ID: 16612594
[TBL] [Abstract][Full Text] [Related]
4. A 21-bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course.
Bos JW; Groen EJN; Otten HG; Budding K; van Eijk RPA; Curial C; Kardol-Hoefnagel T; Goedee HS; van den Berg LH; van der Pol WL
J Peripher Nerv Syst; 2024 Mar; ():. PubMed ID: 38528725
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack.
Okroj M; Corrales L; Stokowska A; Pio R; Blom AM
Cancer Immunol Immunother; 2009 Nov; 58(11):1771-80. PubMed ID: 19259664
[TBL] [Abstract][Full Text] [Related]
6. Complement System Response to Adeno-Associated Virus Vector Gene Therapy.
Kropf E; Markusic DM; Majowicz A; Mingozzi F; Kuranda K
Hum Gene Ther; 2024 Mar; ():. PubMed ID: 38251650
[TBL] [Abstract][Full Text] [Related]
7. CD59 Protects Primary Human Cerebrovascular Smooth Muscle Cells from Cytolytic Membrane Attack Complex.
Whinnery C; Nie Y; Boskovic DS; Soriano S; Kirsch WM
Res Sq; 2024 Apr; ():. PubMed ID: 38645247
[TBL] [Abstract][Full Text] [Related]
8. Engineered IgM and IgG cleaving enzymes for mitigating antibody neutralization and complement activation in AAV gene transfer.
Smith TJ; Elmore ZC; Fusco RM; Hull JA; Rosales A; Martinez M; Tarantal AF; Asokan A
Mol Ther; 2024 May; ():. PubMed ID: 38715362
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated delivery of Factor H attenuates complement C3 induced pathology in the murine retina: a potential gene therapy for age-related macular degeneration.
Cashman SM; Gracias J; Adhi M; Kumar-Singh R
J Gene Med; 2015; 17(10-12):229-43. PubMed ID: 26369397
[TBL] [Abstract][Full Text] [Related]
10. TrkB gene therapy by adeno-associated virus enhances recovery after cervical spinal cord injury.
Martínez-Gálvez G; Zambrano JM; Diaz Soto JC; Zhan WZ; Gransee HM; Sieck GC; Mantilla CB
Exp Neurol; 2016 Feb; 276():31-40. PubMed ID: 26607912
[TBL] [Abstract][Full Text] [Related]
11. Complement System Part I - Molecular Mechanisms of Activation and Regulation.
Merle NS; Church SE; Fremeaux-Bacchi V; Roumenina LT
Front Immunol; 2015; 6():262. PubMed ID: 26082779
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy.
Ruseva MM; Peng T; Lasaro MA; Bouchard K; Liu-Chen S; Sun F; Yu ZX; Marozsan A; Wang Y; Pickering MC
J Am Soc Nephrol; 2016 Feb; 27(2):405-16. PubMed ID: 26047789
[TBL] [Abstract][Full Text] [Related]
13. Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy.
Liu Y; Siriwon N; Rohrs JA; Wang P
Curr Pharm Des; 2015; 21(22):3248-56. PubMed ID: 26027561
[TBL] [Abstract][Full Text] [Related]
14. Regulation of age-related macular degeneration-like pathology by complement factor H.
Toomey CB; Kelly U; Saban DR; Bowes Rickman C
Proc Natl Acad Sci U S A; 2015 Jun; 112(23):E3040-9. PubMed ID: 25991857
[TBL] [Abstract][Full Text] [Related]
15. The membrane attack complex as an inflammatory trigger.
Morgan BP
Immunobiology; 2016 Jun; 221(6):747-51. PubMed ID: 25956457
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of membrane complement regulators improves complement-dependent effector functions of therapeutic anticancer antibodies targeting leukemic cells.
Mamidi S; Höne S; Teufel C; Sellner L; Zenz T; Kirschfink M
Oncoimmunology; 2015 Mar; 4(3):e979688. PubMed ID: 25949896
[TBL] [Abstract][Full Text] [Related]
17. Scalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties.
Qu W; Wang M; Wu Y; Xu R
Curr Pharm Biotechnol; 2015; 16(8):684-95. PubMed ID: 25941887
[TBL] [Abstract][Full Text] [Related]
18. Classical Complement Pathway Activation in the Kidneys of Women With Preeclampsia.
Penning M; Chua JS; van Kooten C; Zandbergen M; Buurma A; Schutte J; Bruijn JA; Khankin EV; Bloemenkamp K; Karumanchi SA; Baelde H
Hypertension; 2015 Jul; 66(1):117-25. PubMed ID: 25941343
[TBL] [Abstract][Full Text] [Related]
19. The role of complement in C3 glomerulopathy.
Zipfel PF; Skerka C; Chen Q; Wiech T; Goodship T; Johnson S; Fremeaux-Bacchi V; Nester C; de Córdoba SR; Noris M; Pickering M; Smith R
Mol Immunol; 2015 Sep; 67(1):21-30. PubMed ID: 25929733
[TBL] [Abstract][Full Text] [Related]
20. Complement regulator CD46: genetic variants and disease associations.
Liszewski MK; Atkinson JP
Hum Genomics; 2015 Jun; 9(1):7. PubMed ID: 26054645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
